We are studying whether the drug ivosidenib can help patients with mIDH1 cholangiocarcinoma after standard chemotherapy. The trial will also look at its safety and effects on quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Cholangiocarcinoma is a rare cancer that forms in the bile ducts, which carry bile from the liver to the small intestine. This trial focuses on the use of ivosidenib as a maintenance therapy following standard adjuvant chemotherapy in patients with curative intent.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.